DR REDDYS LABS ADR/1 IR 5
DR REDDYS LABS ADR/1 IR 5
Certificat de dépôt · US2561352038 · RDY · 659157 (XNYS)
Aperçu
15,54 USD
0,91 % 0,14 USD
NYSE (XNYS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 19:59

Cours actuels de DR REDDYS LABS ADR/1 IR 5

BourseTickerDeviseDernier échangeCoursVariation journalière
XNYS: NYSE
NYSE
RDY
USD
06.06.2025 19:59
15,54 USD
15,53 USD
+0,06 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 5,64 % 14,94 % 20,05 % 6,58 % 8,88 % -70,70 %

Profil de l'entreprise pour DR REDDYS LABS ADR/1 IR 5 Certificat de dépôt

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Données de l'entreprise

Nom DR REDDYS LABS ADR/1 IR 5
Société Dr. Reddy's Laboratories Limited
Symbole RDY
Site web https://www.drreddys.com
Marché d'origine XNYS NYSE
WKN 659157
ISIN US2561352038
Type de titre Certificat de dépôt
Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic
PDG Mr. Erez Israeli M.B.A.
Capitalisation boursière 11 Mrd.
Pays Inde
Devise USD
Employés 27,0 T
Adresse 8-2-337, Road No. 3, 500034 Hyderabad
Date d'introduction en bourse 2001-04-11

Fractionnements d'actions

Date Fractionnement
05.11.2024 5:1
07.09.2006 2:1

Symboles boursiers

Nom Symbole
Frankfurt RDDA.F
NYSE RDY

Autres actions

Les investisseurs qui détiennent DR REDDYS LABS ADR/1 IR 5 ont également les actions suivantes dans leur portefeuille :
AMAZON.CO INC
AMAZON.CO INC Action
APPLE INC
APPLE INC Action
ASML HOLDING
ASML HOLDING Action
HITACHI LTD
HITACHI LTD Action
HUGO BOSS
HUGO BOSS Action
ISIV-NASDAQ US BIOTE. DLA
ISIV-NASDAQ US BIOTE. DLA ETF
LB.HESS.-THR.ZI.EX.02B/14
LB.HESS.-THR.ZI.EX.02B/14 Obligation
LYXOR COMMO EX AGRI ETF I
LYXOR COMMO EX AGRI ETF I ETF
NETFLIX INC
NETFLIX INC Action
NIKE INC - CLASS B
NIKE INC - CLASS B Action
NVIDIA CORP
NVIDIA CORP Action
SHOPIFY A SUB.VTG
SHOPIFY A SUB.VTG Action
SIGMA FINANCE CORPORATION (DO NOT PROCESS LINE REMOVALS / REDEMPTIONS) FLTG RTE NTS 30/10/09
SIGMA FINANCE CORPORATION (DO NOT PROCESS LINE REMOVALS / REDEMPTIONS) FLTG RTE NTS 30/10/09 Obligation
SYMRISE AG
SYMRISE AG Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025